Download PDF
Dtsch Med Wochenschr 2009; 134(16): 835-844
DOI: 10.1055/s-0029-1220235
CME-Beitrag | Review article
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Myokarditis

MyocarditisM. Pauschinger1 , J. Bilger1 , J. Schwab1
  • 1Medizinische Klinik 8, Kardiologie, Klinikum Nürnberg
Further Information

Publication History

eingereicht: 14.11.2008

akzeptiert: 2.4.2009

Publication Date:
07 April 2009 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Myokarditis - Diagnostik - Therapie - MRT - Herzmuskelbiopsie

Keywords

myocarditis - diagnosis - therapy - MRI - myocardiaal biopsy

Literatur

  • 1 Abril A, Calamia K T, Cohen M D. The Churg Strauss syndrome: review and update.  Semin Arthritis Rheum. 2003;  33 106-114
    Google Scholar
  • 2 Aretz H T, Billingham M E, Edwards W D. et al . Myocarditis. A histopathologic definition and classification.  Am J Cardiovasc Pathol. 1987;  1 3-14
    Google Scholar
  • 3 Bardy G H. et al . Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure.  N Engl J Med. 2005;  352 225-37
    Google Scholar
  • 4 Baughman K L. Diagnosis of myocarditis: death of Dallas criteria.  Circulation. 2006;  113 593-595
    Google Scholar
  • 5 Brilakis E S, Olson L J, Berry G J. et al . Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices.  Asaio J. 2000;  46 569-572
    Google Scholar
  • 6 Cleland J GF, Daubert J C, Erdmann E. et al . The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure.  N Engl J Med. 2005;  352 1539-1549
    Google Scholar
  • 7 Cooper L T, Baughman K L, Feldman A M. et al . The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.  Circulation. 2007;  116 2216-2233
    Google Scholar
  • 8 Corssmit E P, Trip M D, Durrer J D. Loffler’s endomyocarditis in the ideopathic hypereosinophilic syndrome.  Cardiology. 1999;  91 272-276
    Google Scholar
  • 9 D’Ambrosio A, Patti G, Manzoli A. et al . The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.  Heart. 2001;  85 499-504
    Google Scholar
  • 10 Dickstein K, Cohen-Solal A, Filippatos G. et al . ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008.  Eur J Heart Fail. 2008;  10 933-989
    Google Scholar
  • 11 Felix S B, Staudt A. Immunoadsorption for treatment of dilated cardiomyopathy.  Internist. 2008;  49 51-56
    Google Scholar
  • 12 Frustaci A, Chimenti C, Calabrese F. et al . Immunosuppressive therapy for active lymphocytic myocarditis: virologic and immunologic profile of responders versus non-responders.  Circulation. 2003;  107 857-863
    Google Scholar
  • 13 Gutberlet M, Spors B, Thima T. et al . Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence.  Radiology. 2008;  246 401-409
    Google Scholar
  • 14 Holzmann M, Nicko A, Kuhl U. et al . Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over a 11-year period.  Circulation. 2008;  118 1722-1728
    Google Scholar
  • 15 Kindermann I, Kindermann M, Kandolf R. et al . Predictors of outcome in patients with suspected myocarditis.  Circulation. 2008;  118 639-648
    Google Scholar
  • 16 Kuhl U, Lassner D, Pauschinger M. et al . Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy.  J Med Virol. 2008;  80 1243-1251
    Google Scholar
  • 17 Kuhl U, Noutsias M, Seeberg B. et al . Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.  Heart. 1996;  75 295-300
    Google Scholar
  • 18 Kuhl U, Pauschinger M, Bock T. et al . Parvovirus B19 infection mimicking acute myocardial infarction.  Circulation. 2003;  108 945-950
    Google Scholar
  • 19 Kuhl U, Pauschinger M, Noutsias M. et al . High prevalence of viral genomes and multiple viral infections in the myocardium of adults with „idiopathic” left ventricular dysfunction.  Circulation. 2005;  111 887-893
    Google Scholar
  • 20 Kuhl U, Pauschinger M, Schwimmbeck P L. et al . Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.  Circulation. 2003;  107 2793-2798
    Google Scholar
  • 21 Kuhl U, Schultheiss H P. Treatment of chronic myocarditis with corticosteroids.  Eur Heart J. 1995;  16 168-172
    Google Scholar
  • 22 Kuhl U, Seeberg B, Noutsias M. et al . Viral persistence in the myocardium is associated with progressive cardiac dysfunction.  Circulation. 2005;  112 1965-1970
    Google Scholar
  • 23 Lauer B, Niederau C, Kühl U. et al . Cardiac Troponin T in Patients With Clinically Suspected Myocarditis.  J Am Coll Cardiol. 1997;  30 1354-1359
    Google Scholar
  • 24 Liu P P, Schultheiss H -P. Myocarditis.  In: Peter Libby et al. Braunwald’s heart disease: a textbook of cardiovascular medicine. 8th edition. Saunders Elsevier 2008: 1775ff
    Google Scholar
  • 25 Mangin M, Mahrholdt H, Sechtem U. Diagnostik der Myokarditis: Darstellung und Bewertung der verfügbaren Methoden.  Dtsch Med Wochenschr. 2006;  131 1228-1234
    Google Scholar
  • 26 Mahrholdt H, Wagner A, Deluigi C C. et al . Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis.  Circulation. 2006;  114 1581-90
    Google Scholar
  • 27 Mahrholdt H, Goedecke C, Wagner A. et al . Cardiovascular Magnetic resonance Assessment of Human Myocarditis.  Circulation. 2004;  109 1250-1258
    Google Scholar
  • 28 Maron B J, Towbin J A, Thiene G. et al . Contemporary definitions and classification of the cardiomyopathies.  Circulation. 2006;  113 1807-16
    Google Scholar
  • 29 Maron B J, Ackerman M J. et al . Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome.  J Am Coll Cardiol. 2005;  45 1340-1345
    Google Scholar
  • 30 Martin J, Sarai K, Schindler M. et al . MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis.  Ann Thorac Surg. 1997;  63 1145-1146
    Google Scholar
  • 31 Mason J W, O’Connell J B, Herskowitz A. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.  N Engl J Med. 1995;  333 269-275
    Google Scholar
  • 32 Pauschinger M, Bowles N E, Fuentes-Garcia F J. et al . Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction.  Circulation. 1999;  99 1348-1354
    Google Scholar
  • 33 Pauschinger M, Noutsias M, Lassner D. et al . Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?.  Clin Res Cardiol. 2006;  95 569-583
    Google Scholar
  • 34 Schultheiss H P, Piper C, Sowade O. et al . The effect of subcutaneous treatment with Interferon-Beta-1b over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy.  Circulation. 2008;  118 2312
    Google Scholar
  • 35 Tschope C, Bock C T, Kasner M. et al . High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.  Circulation. 2005;  111 879-886
    Google Scholar
  • 36 Why H J, Meany B T, Richardson P J. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.  Circulation. 1994;  89 2582-2589
    Google Scholar
  • 37 Wojnicz R, Nowalany-Kozielska E, Wojciechowska C. et al . Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy : Two-Year Follow-Up Results.  Circulation. 2001;  104 39-45
    Google Scholar

Prof. Dr. med. M. Pauschinger

Medizinische Klinik 8, Kardiologie, Klinikum Nürnberg

Breslauer Straße 201

90471 Nürnberg

Phone: 0911/398-2990

Fax: 0911/398-2988

Email: matthias.pauschinger@klinikum-nuernberg

      >